1. Home
  2. CDXC vs XPOF Comparison

CDXC vs XPOF Comparison

Compare CDXC & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • XPOF
  • Stock Information
  • Founded
  • CDXC 1999
  • XPOF 2017
  • Country
  • CDXC United States
  • XPOF United States
  • Employees
  • CDXC N/A
  • XPOF N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • CDXC Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • CDXC Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • CDXC 415.5M
  • XPOF 388.8M
  • IPO Year
  • CDXC N/A
  • XPOF 2021
  • Fundamental
  • Price
  • CDXC $5.48
  • XPOF $13.93
  • Analyst Decision
  • CDXC Strong Buy
  • XPOF Buy
  • Analyst Count
  • CDXC 2
  • XPOF 10
  • Target Price
  • CDXC $8.00
  • XPOF $16.75
  • AVG Volume (30 Days)
  • CDXC 587.4K
  • XPOF 366.2K
  • Earning Date
  • CDXC 10-31-2024
  • XPOF 02-27-2025
  • Dividend Yield
  • CDXC N/A
  • XPOF N/A
  • EPS Growth
  • CDXC N/A
  • XPOF N/A
  • EPS
  • CDXC 0.02
  • XPOF N/A
  • Revenue
  • CDXC $91,668,000.00
  • XPOF $326,724,000.00
  • Revenue This Year
  • CDXC $18.64
  • XPOF $1.79
  • Revenue Next Year
  • CDXC $20.72
  • XPOF $7.50
  • P/E Ratio
  • CDXC $274.95
  • XPOF N/A
  • Revenue Growth
  • CDXC 9.95
  • XPOF 9.00
  • 52 Week Low
  • CDXC $1.36
  • XPOF $7.40
  • 52 Week High
  • CDXC $7.97
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 39.30
  • XPOF 48.63
  • Support Level
  • CDXC $5.26
  • XPOF $12.57
  • Resistance Level
  • CDXC $5.56
  • XPOF $16.00
  • Average True Range (ATR)
  • CDXC 0.29
  • XPOF 0.82
  • MACD
  • CDXC -0.09
  • XPOF -0.11
  • Stochastic Oscillator
  • CDXC 18.88
  • XPOF 39.65

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: